0.94
0.02 (2.17%)
0.02 (2.17%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| VIVUS Inc | VVUS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0422 | -4.39% | 0.92 | 0.9154 | 1.00 | 0.97 | 0.9622 | 00:00:05 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.94 | 2.25 | 1.31 | 58.22% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 409 | 170,107 | $ 0.9369013 | $ 159,373 | 212,067 | 0.80 - 4.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:21:48 | 1 | $ 0.94 | USD |
VIVUS Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 9.80M | 10.65M | $ -36.95M | -2.96 | -0.32 | 8.18M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
VIVUS News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VVUS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.03 | 1.09 | 0.8011 | 0.9735994 | 230,750 | -0.11 | -10.68% |
| 1 Month | 1.80 | 2.46 | 0.80 | 1.25 | 213,309 | -0.88 | -48.89% |
| 3 Months | 2.65 | 4.15 | 0.80 | 3.08 | 739,252 | -1.73 | -65.28% |
| 6 Months | 3.80 | 4.3499 | 0.80 | 3.09 | 384,303 | -2.88 | -75.79% |
| 1 Year | 4.24 | 4.78 | 0.80 | 3.22 | 230,456 | -3.32 | -78.3% |
| 3 Years | 11.10 | 13.80 | 0.80 | 7.00 | 495,562 | -10.18 | -91.71% |
| 5 Years | 25.10 | 26.50 | 0.80 | 11.90 | 741,579 | -24.18 | -96.33% |
VIVUS Description
| VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. |
